|
Volumn 102, Issue 11, 2000, Pages
|
Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary.
a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENIC FACTOR;
ENDOTHELIAL CELL GROWTH FACTOR;
FIBROBLAST GROWTH FACTOR 2;
LYMPHOKINE;
VASCULOTROPIN;
VASCULOTROPIN A;
ANGIOCARDIOGRAPHY;
ANGIOGENESIS;
ANIMAL;
CLINICAL TRIAL;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
CORONARY BLOOD VESSEL;
GENE THERAPY;
GENETICS;
HEART DISEASE;
HUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATIENT SELECTION;
RADIOGRAPHY;
REVIEW;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
ANGIOGENESIS INDUCING AGENTS;
ANIMALS;
CLINICAL TRIALS;
CORONARY ANGIOGRAPHY;
CORONARY VESSELS;
ENDOTHELIAL GROWTH FACTORS;
FIBROBLAST GROWTH FACTOR 2;
GENE THERAPY;
HEART DISEASES;
HUMANS;
LYMPHOKINES;
MAGNETIC RESONANCE IMAGING;
NEOVASCULARIZATION, PHYSIOLOGIC;
PATIENT SELECTION;
TOMOGRAPHY, EMISSION-COMPUTED;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
EID: 0034641624
PISSN: None
EISSN: 15244539
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (431)
|
References (95)
|